Abstract
Behçet’s disease is infrequently associated with hematological, auditory, renal, and urological abnormalities. The most significant hematological alteration is the myelodysplastic syndrome, usually linked to trisomy 8. The development of BD-like symptoms in patients with chronic myelogenous leukemia has also been reported. Hearing loss, mostly of the sensorineural type seems to be more common than generally realized. It is usually indolent in nature and may be uni or bilateral. Renal involvement is rare as contrasted to the ANCA-associated vasculitides. However, it may be seen in the form of AA amyloidosis or as glomerulonephritis. Renal vascular disease or interstitial involvement may occasionally be observed. Successful transplantation in end-stage renal disease has been reported. Primary bladder involvement due to vasculitis and secondary involvement due to neuro-Behçet are examples of urological manifestations. They usually present with hematuria or voiding difficulties. Epididymitis and impotence are also seen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rosenthal NS, Farhi DC (1996) Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol 106(5):676–679
Lee KY, do Kim Y, Chang JY, Bang D (2008) Two cases of acute leukopenia induced by colchicine with concurrent immunosuppressants use in Behçet’s disease. Yonsei Med J 49(1):171–173
Fine LA, Hoffman LD, Hoffman MD (2007) Aphthous ulcerations associated with trisomy 8-positive myelodysplastic syndrome. J Am Acad Dermatol 57(2 Suppl):S38–S41
Ahn JK, Cha HS, Koh EM et al (2008) Behçet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47(8):1228–1230
Lin YC, Liang TH, Chang HN, Lin JS, Lin HY (2008) Behçet’s disease associated with myelodysplastic syndrome. J Clin Rheumatol 14(3):169–174
Fujita H, Kiriyama M, Kawamura T et al (2002) Massive hemorrhage in a patient with intestinal Behçet’s disease: report of a case. Surg Today 32(4):378–382
Arimura K, Arima N, Matsushita K et al (2007) High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet’s disease. J Clin Immunol 27(2):145–151
Ohno E, Ohtsuka E, Watanabe K et al (1997) Behçet’s disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer 79(2):262–268
Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M (2001) Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis – Behçet’s syndrome. Leuk Lymphoma 42(1–2):115–121
Kawabata H, Sawaki T, Kawanami T et al (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 45(22):1309–1314
Eder L, Rozenbaum M, Boulman N et al (2005) Behçet’s disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement – an association. Clin Exp Rheumatol 23(4 Suppl 38):S91–S95
Bangerter M, Griesshammer M, Tirpitz Cv et al (1999) Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet’s disease. Scand J Rheumatol 28(2):117–119
Michels SD, McKenna RW, Arthur DC, Brunning RD (1985) Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 65(6):1364–1372
Nonami A, Takenaka K, Sumida C et al (2007) Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet’s disease by up-front cord blood transplantation. Intern Med 46(20):1753–1756
Tomonari A, Tojo A, Takahashi T et al (2004) Resolution of Behçet’s disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol 83(7):464–466
Yamato K (2003) Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet’s disease. Int J Hematol 77(1):82–85
Demiroglu H, Dundar S (1997) Behçet’s disease and neutropenia. Int J Dermatol 36(7):557–559
Rogers RS 3rd (1997) Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 16(4):278–283
Leiferman KM, O’Duffy JD, Perry HO, Greipp PR, Giuliani ER, Gleich GJ (1982) Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA 247(7):1018–1020
Budak-Alpdogan T, Demircay Z, Alpdogan O et al (1997) Behçet’s disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet’s symptoms. Ann Hematol 74(1):45–48
Segawa F, Shimizu Y, Saito E, Kinoshita M (1995) Behçet’s disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol 22(6):1183–1184
Budak-Alpdogan T, Demircay Z, Alpdogan O et al (1998) Skin hyperreactivity of Behçet’s patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol 37(11):1148–1151
Vaiopoulos G, Terpos E, Viniou N, Nodaros K, Rombos J, Loukopoulos D (2001) Behçet’s disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature. Am J Hematol 66(1):57–58
Karincaoglu Y, Kaya E, Esrefoglu M, Aydogdu I (2003) Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behçet’s disease. Leuk Lymphoma 44(6):1063–1065
Cakmak SK, Gul U, Kilic A, Gonul M, Soylu S, Demirel O (2006) Behçet’s disease associated with chronic myelogenous leukemia and chronic graft-vs-host disease. Leuk Lymphoma 47(12):2674–2675
Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behçet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23(4 Suppl 38):S35–S41
Bakhshaee M, Ghasemi MM, Hatef MR, Talebmehr M, Shakeri MT (2007) Hearing loss in Behçet’s syndrome. Otolaryngol Head Neck Surg 137(3):439–442
Ak E, Harputluoglu U, Oghan F, Baykal B (2004) Behçet’s disease and hearing loss. Auris Nasus Larynx 31(1):29–33
Kulahli I, Balci K, Koseoglu E, Yuce I, Cagli S, Senturk M (2005) Audio-vestibular disturbances in Behçet’s patients: report of 62 cases. Hear Res 203(1–2):28–31
Bayazit YA, Yilmaz M, Gunduz B et al (2007) Distortion product otoacoustic emission findings in Behçet’s disease and rheumatoid arthritis. ORL J Otorhinolaryngol Relat Spec 69(4): 233–238
Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A (2001) Audio-vestibular evaluation in patients with Behçet’s syndrome. J Laryngol Otol 115(9):704–708
Brama I, Fainaru M (1980) Inner ear involvement in Behçet’s disease. Arch Otolaryngol 106(4):215–217
Soylu L, Aydogan B, Soylu M, Ozsahinoglu C (1995) Hearing loss in Behçet’s disease. Ann Otol Rhinol Laryngol 104(11):864–867
Gemignani G, Berrettini S, Bruschini P et al (1991) Hearing and vestibular disturbances in Behçet’s syndrome. Ann Otol Rhinol Laryngol 100(6):459–463
Dagli M, Eryilmaz A, Tanrikulu S et al (2008) Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet’s disease. Auris Nasus Larynx 35(3):333–337
Muluk NB, Birol A (2007) Effects of Behçet’s disease on hearing thresholds and transient evoked otoacoustic emissions. J Otolaryngol 36(4):220–226
Pollak L, Luxon LM, Haskard DO (2001) Labyrinthine involvement in Behçet’s syndrome. J Laryngol Otol 115(7):522–529
Smith LN (1994) Unilateral sensorineural hearing loss in Behçet’s disease. Am J Otolaryngol 15(4):286–288
Choung YH, Cho MJ, Park K, Choi SJ, Shin YR, Lee ES (2006) Audio-vestibular disturbance in patients with Behçet’s disease. Laryngoscope 116(11):1987–1990
Igarashi Y, Watanabe Y, Aso S (1994) A case of Behçet’s disease with otologic symptoms. ORL J Otorhinolaryngol Relat Spec 56(5):295–298
Adler YD, Jovanovic S, Jivanjee A, Krause L, Zouboulis CC (2002) Adamantiades–Behçet’s disease with inner ear involvement. Clin Exp Rheumatol 20(4 Suppl 26):S40–S42
Elidan J, Levi H, Cohen E, BenEzra D (1991) Effect of cyclosporine A on the hearing loss in Behçet’s disease. Ann Otol Rhinol Laryngol 100(6):464–468
Quaranta N, Bartoli R, Giagnotti F, Di Cuonzo F, Quaranta A (2002) Cochlear implants in systemic autoimmune vasculitis syndromes. Acta Otolaryngol Suppl 548:44–48
Szilvassy J, Czigner J, Jori J et al (1998) Cochlear implantation of a Hungarian deaf and blind patient with discharging ears suffering from Behçet’s disease. J Laryngol Otol 112(2):169–171
Barna BP, Hughes GB (1988) Autoimmunity and otologic disease: clinical and experimental aspects. Clin Lab Med 8(2):385–398
Akpolat T, Dilek M, Aksu K, Keser G, Toprak O, Cirit M, Oğuz Y, Taşkapan H, Adibelli Z, Akar H, Tokgöz B, Arici M, Celiker H, Diri B, Akpolat I (2008) Renal Behçet’s disease: an update. Semin Arthritis Rheum 38:241–248
Rosenthal T, Weiss P, Gafni J (1978) Renal involvement in Behçet’s syndrome. Arch Intern Med 138:1122–1124
Kaklamani VG, Nikolopoulou N, Sotsiou F, Billis A, Kaklamanis P (2001) Renal involvement in Adamantiades–Behçet’s disease. Case report and review of the literature. Clin Exp Rheumatol 19(5 Suppl 24):S55–S58
Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S (2002) Renal Behçet’s disease: a cumulative analysis. Semin Arthritis Rheum 31:317–337
Akpolat T, Diri B, Oğuz Y, Yilmaz E, Yavuz M, Dilek M (2003) Behçet’s disease and renal failure. Nephrol Dial Transplant 18:888–891
Akpolat T, Yilmaz E, Akpolat I, Dilek M, Karagoz F, Balci B, Ozen S (2002) Amyloidosis in Behçet’s disease and familial Mediterranean fever. Rheumatology (Oxford) 41:592–593
Dilsen N, Konice M, Aral O, Erbengi T, Uysal V, Kocak N, Ozdogan E (1988) Behçet’s disease associated with amyloidosis in Turkey and in the world. Ann Rheum Dis 47:157–163
Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H (1990) Amyloidosis in Behçet’s syndrome. Arthritis Rheum 33:1586–1589
Melikoglu M, Altiparmak MR, Fresko I, Tunc R, Yurdakul S, Hamuryudan V, Yazici H (2001) A reappraisal of amyloidosis in Behçet’s syndrome. Rheumatology (Oxford) 40:212–215
Chiba M, Inoue Y, Arakawa H, Masamune O, Ohkubo M (1987) Behçet’s disease associated with amyloidosis. Gastroenterol Jpn 22:487–495
Rosenthal T, Bank H, Aladjem M, David R, Gafni J (1975) Systemic amyloidosis in Behçet’s disease. Ann Intern Med 83:220–223
Utku U, Dilek M, Akpolat I, Bedir A, Akpolat T (2007) SAA1 alpha/alpha alleles in Behçet’s disease related amyloidosis. Clin Rheumatol 26:927–929
Tasdemir I, Sivri B, Turgan C, Emri S, Yasavul U, Caglar S (1989) The expanding spectrum of a disease. Behçet’s disease associated with amyloidosis. Nephron 52:154–157
Altiparmak MR, Tanverdi M, Pamuk ON, Tunc R, Hamuryudan V (2002) Glomerulonephritis in Behçet’s disease: report of seven cases and review of the literature. Clin Rheumatol 21:14–18
Gürler A, Boyvat A, Türsen U (1997) Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427
Finucane P, Doyle CT, Ferriss JB, Molloy M, Murnaghan D (1985) Behçet’s syndrome with myositis and glomerulonephritis. Br J Rheumatol 24:372–375
Tietjen DP, Moore WJ (1990) Treatment of rapidly progressive glomerulonephritis due to Behçet’s syndrome with intravenous cyclophosphamide. Nephron 55:69–73
Fukuda Y, Hayashi H (1982) Renal involvement in Behçet’s disease. Ensyo 2:545–548
Sugiyama E, Suzuki H, Akagawa N, Yamashita N, Yano S, Iida H, Kitagawa M (1984) [Behçet’s disease associated with IgA nephropathy: report of a case]. Nippon Naika Gakkai Zasshi 73:1818–1822
Sudo J, Matsubara T, Iwai H, Ueda Y, Kameda S, Iwata T et al (1987) IgA nephropathy developed in a patient with Behçet’s disease. Kidney dial 22:893–897
Donnelly S, Jothy S, Barré P (1989) Crescentic glomerulonephritis in Behçet’s syndrome – results of therapy and review of the literature. Clin Nephrol 31:213–218
Hamuryudan V, Yurdakul S, Kural AR, Ince U, Yazici H (1991) Diffuse proliferative glomerulonephritis in Behçet’s syndrome. Br J Rheumatol 30:63–64
El Ramahi KM, Al Dalaan A, Al Shaikh A, Al Meshari K, Akhtar M (1998) Renal involvement in Behçet’s disease: review of 9 cases. J Rheumatol 25:2254–2260
Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S et al (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410
Sueyoshi E, Sakamoto I, Hayashi N, Fukuda T, Matsunaga N, Hayashi K, Inoue K (1996) Ruptured renal artery aneurysm due to Behçet’s disease. Abdom Imaging 21:166–167
Sherif A, Stewart P, Mendes DM (1992) The repetitive vascular catastrophes of Behçet’s disease: a case report with review of the literature. Ann Vasc Surg 6:85–89
Han K, Siegel R, Pantuck AJ, Gazi MA, Burno DK, Weiss RE (1999) Behçet’s syndrome with left ventricular aneurysm and ruptured renal artery pseudoaneurysm. Urology 54:162
Fukuda T, Hayashi K, Sakamoto I, Mori M (1995) Acute renal infarction caused by Behçet’s disease. Abdom Imaging 20:264–266
Malik GH, Sirwal IA, Pandit KA (1989) Behçet’s syndrome associated with minimal change glomerulonephritis and renal vein thrombosis. Nephron 52:87–89
Angotti C, D’Cruz DP, Abbs IC, Hughes GR (2003) Renal microinfarction in Behçet’s disease. Rheumatology (Oxford) 42:1416–1417
Planer D, Verstandig A, Chajek-Shaul T (2001) Transcatheter embolization of renal artery aneurysm in Behçet’s disease. Vasc Med 6:109–112
Apaydin S, Erek E, Ulkü U, Hamuryudan V, Yazici H, Sariyar M (1999) A successful renal transplantation in Behçet’s syndrome. Ann Rheum Dis 58:719
Kirkali Z, Yigitbasi O, Sasmaz R (1991) Urological aspects of Behçet’s disease. Br J Urol 67(6):638–639
Sharquie KE, Al-Rawi Z (1987) Epididymo-orchitis in Behçets disease. Br J Rheumatol 26(6):468–469
Kaklamani VG, Vaiopoulos G, Markomichelakis N, Kaklamanis P (2000) Recurrent epididymo-orchitis in patients with Behçet’s disease. J Urol 163(2):487–489
Callejas-Rubio JL, Ortego N, Diez A, Castro M, De La Higuera J (1998) Recurrent epididymo-orchitis secondary to Behçets disease. J Urol 160(2):496
Pannek J, Haupt G (1997) Orchitis due to vasculitis in autoimmune diseases. Scand J Rheumatol 26(3):151–154
Eilber KS, Freedland SJ, Rajfer J (2001) Polyarteritis nodosa presenting as hematuria and a testicular mass. J Urol 166(2):624
Mayer DF, Matteson EL (2004) Testicular involvement in rheumatoid vasculitis. Clin Exp Rheumatol 22(6 Suppl 36):S62–S64
Joudi FN, Austin JC, Vogelgesang SA, Jensen CS (2004) Isolated testicular vasculitis presenting as a tumor-like lesion. J Urol 171(2 Pt 1):799
Ek L, Hedfors E (1993) Behçet’s disease: a review and a report of 12 cases from Sweden. Acta Derm Venereol 73(4):251–254
Zouboulis CC, Kotter I, Djawari D et al (1997) Epidemiological features of Adamantiades–Behçet’s disease in Germany and in Europe. Yonsei Med J 38(6):411–422
Fuse H, Ohkawa M, Yamaguchi K, Hirata A, Matsubara F (1995) Cryptococcal prostatitis in a patient with Behçet’s disease treated with fluconazole. Mycopathologia 130(3):147–150
Chajek T, Fainaru M (1975) Behçet’s disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 54(3):179–196
Carswell GF (1976) A case of Behçet’s disease involving the bladder. Br J Urol 48(3): 199–202
McDonald GS, Gad-Al-Rab J (1980) Behçet’s disease with endocarditis and the Budd–Chiari syndrome. J Clin Pathol 33(7):660–669
Ates A, Aydintug OT, Duzgun N, Yaman O, Sancak T, Omur ND (2004) Behçet’s disease presenting as deep venous thrombosis and priapism. Clin Exp Rheumatol 22(1):107–109
Moalla M, Gabsi M, el Ouakdi M, Zmerli S, Ben Ayed H (1990) Behçet disease and priapism. J Rheumatol 17(4):570–571
Erdogru T, Kocak T, Serdaroglu P, Kadioglu A, Tellaloglu S (1999) Evaluation and therapeutic approaches of voiding and erectile dysfunction in neurological Behçet’s syndrome. J Urol 162(1):147–153
Kone-Paut I, Yurdakul S, Bahabri SA et al (1998) Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. J Pediatr 132(4):721–725
Shaefei N, Shahram F, Davatchi F et al (1998) Comparison of juvenile with adult Behçet’s disease (A). Arthritis Rheum 41(S124)
Pektas A, Devrim I, Besbas N, Bilginer Y, Cengiz AB, Ozen S (2008) A child with Behçet’s disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis. Turk J Pediatr 50(1):78–80
Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16(8):790–795
Dokmeci F, Cengiz B, Ortac F (1996) Pelvic mass in a patient with Behçet’s disease. Obstet Gynecol 87(5 Pt 2):881
Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H (1998) Urologic screening for men with Behçet’s syndrome. Urology 52(5):863–865
Monteiro H, Nogueira R, de Carvalho H (1995) Behçet’s syndrome and vesicovaginal fistula: an unusual complication. J Urol 153(2):407–408
Aoki T, Tanaka T, Akifuji Y et al (2000) Beneficial effects of interferon-alpha in a case with Behçet’s disease. Intern Med 39(8):667–669
Saito M, Miyagawa I (2000) Bladder dysfunction due to Behçet’s disease. Urol Int 65(1): 40–42
Karandreas N, Tsivgoulis G, Zambelis T et al (2007) Urinary frequency in a case of Neuro-Behçet disease involving the brainstem - clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg 109(9):806–810
Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122(Pt 11):2171–2182
Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14(7):729–737
Szymajda A, Eledrisi MS, Patel R, Chaljub G, Cepeda E, Kaushik P (2003) Diabetes insipidus as a consequence of neurologic involvement in Behçet’s syndrome. Endocr Pract 9(1): 33–35
Jin-No M, Fujii T, Jin-No Y, Kamiya Y, Okada M, Kawaguchi M (1999) Central diabetes insipidus with Behçet’s disease. Intern Med 38(12):995–999
Cetinel B, Akpinar H, Tufek I, Uygun N, Solok V, Yazici H (1999) Bladder involvement in Behçet’s syndrome. J Urol 161(1):52–56
Theodorou C, Floratos D, Hatzinicolaou P, Vaiopoulos G (1999) Neurogenic bladder dysfunction due to Behçet’s disease. Int J Urol 6(8):423–425
Celik I, Altundag K, Erman M, Baltali E (1999) Cyclophosphamide-associated carcinoma of the urinary bladder in Behçet’s disease. Nephron 81(2):239
Baltaci S, Gogus C, Karamursel T, Tulunay O (2003) Invasive bladder carcinoma in a patient with Behçet’s disease. Int J Urol 10(12):669–671
Sarica K, Suzer O, Gurler A, Baltaci S, Ozdiler E, Dincel C (1995) Urological evaluation of Behçet patients and the effect of colchicine on fertility. Eur Urol 27(1):39–42
Korkmaz C, Ozcan A, Akcar N (2005) Increased frequency of ultrasonographic findings suggestive of renal stones in patients with ankylosing spondylitis. Clin Exp Rheumatol 23(3):389–392
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Calamia, K.T., Fresko, İ. (2010). Miscellaneous Manifestations of Behçet’s Disease. In: Yazıcı, Y., Yazıcı, H. (eds) Behçet’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5641-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5641-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5640-8
Online ISBN: 978-1-4419-5641-5
eBook Packages: MedicineMedicine (R0)